ACCESS SOLUTIONS Trademark

Trademark Overview


On Monday, July 31, 2017, a trademark application was filed for ACCESS SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the ACCESS SOLUTIONS trademark a serial number of 87550303. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, December 31, 2024. This trademark is owned by GENENTECH, INC.. The ACCESS SOLUTIONS trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payor reimbursement for prescription drugs; insurance administration of patient reimbursement programs; providing on-line information in the fields of health care insurance coverage and insurance claims administration

Billing services in the field of healthcare and pharmaceutical products; providing on-line information in the nature of billing services information; business administration of patient reimbursement plans
access solutions

General Information


Serial Number87550303
Word MarkACCESS SOLUTIONS
Filing DateMonday, July 31, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, December 31, 2024
Registration Number5538665
Registration DateTuesday, August 14, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements


Goods and ServicesPrescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payor reimbursement for prescription drugs; insurance administration of patient reimbursement programs; providing on-line information in the fields of health care insurance coverage and insurance claims administration
Goods and ServicesBilling services in the field of healthcare and pharmaceutical products; providing on-line information in the nature of billing services information; business administration of patient reimbursement plans

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, August 4, 2017
Primary Code035
First Use Anywhere DateThursday, January 31, 2008
First Use In Commerce DateThursday, January 31, 2008

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, August 4, 2017
Primary Code036
First Use Anywhere DateThursday, January 31, 2008
First Use In Commerce DateThursday, January 31, 2008

Trademark Owner History


Party NameGENENTECH, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, November 7, 2017NON-FINAL ACTION E-MAILED
Thursday, August 3, 2017NEW APPLICATION ENTERED
Friday, August 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 31, 2017ASSIGNED TO EXAMINER
Tuesday, November 7, 2017NON-FINAL ACTION WRITTEN
Thursday, February 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 7, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 22, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 21, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 19, 2018FINAL REFUSAL WRITTEN
Monday, March 19, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 19, 2018FINAL REFUSAL E-MAILED
Wednesday, March 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2018LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, April 25, 2018LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 31, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018REGISTERED-PRINCIPAL REGISTER
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 14, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 31, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, April 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 28, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 31, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 31, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.